Gingko Bioworks, valued at $15B, begins trading today: Here’s how their business works
11:08am PDT - September 17th, 2021 stock market - TechCrunchGingko Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Gingko’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the company. It’s…